The family of a pregnant HIV-positive woman who died during a clinical trial evaluating the use of anti-HIV medications to prevent mother-to-child HIV transmissions has filed a $10 million lawsuit against drugmakers Boehringer Ingelheim and GlaxoSmithKline as well as doctors and hospitals involved in the study. Family members say they did not learn that the National Institutes of Health concluded the drugs used most likely caused the woman's death until the Associated Press uncovered the case file.
